SEC Filing Details

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

SEC Filing Details

Document Details

Form
Filing Date
May 5, 2021
Document Date
Mar 31, 2021
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Luminex Corporation
Issuer
LUMINEX CORP

Shareholder Tools